Reducing Morbidity and Mortality in Patients with CKD in T2D: New Late-Breaking Data
Pam R. Taub, MD, FACC, FASPC
George L. Bakris, MD, FAHA, FASN
Gerasimos S. Filippatos, MD, FESC, FHFA, FHFSA(h)
Worsening Heart Failure: The How, Why, and When of Novel Treatment Options
Shelley Zieroth, MD
A New Option for Cardiorenal Protection for Patients with CKD in T2D
Javier Morales, MD, FACP, FACE
Angela Yee-Moon Wang, MD, FACP, FACE
